Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions.

epithelial carcinomas eyelid histology of the skin line-field confocal optical coherence tomography melanoma non-invasive diagnosis skin cancers

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
03 Dec 2023
Historique:
received: 09 11 2023
revised: 29 11 2023
accepted: 01 12 2023
medline: 9 12 2023
pubmed: 9 12 2023
entrez: 9 12 2023
Statut: epublish

Résumé

Periocular malignancies may be clinically different from the examples arising at other sites, with possible delayed diagnosis and greater challenges for treatment and repair. Line-field confocal optical coherence tomography (LC-OCT) is a recently developed technique characterized by an unprecedented capacity to acquire high-definition images in vertical and horizontal modes. In this study, we aimed to investigate the LC-OCT morphological features of a series of eyelid skin lesions, correlating them to histopathological findings. Patients with biopsy-proven equivocal skin lesion in the eyelid area, previously investigated by means of LC-OCT, were included in the study. Percentage overall agreement was estimated for LC-OCT and histopathological diagnosis for study cases. A total of 51 patients (28 women, 23 men; mean age 66.4 years old), for a total of 51 skin lesions, were assessed. The histopathological diagnosis consisted of 30 malignant and 21 benign tumors. Different entities were characterized by peculiar findings in LC-OCT, alike to histopathological features, allowing for an accurate "in vivo" classification in almost all cases, with a diagnostic concordance with histopathology of 92.1% (47/51). By integrating this new imaging technique into the assessment of suspicious tumors in this area, diagnostic accuracy may increase, improving strategies adopted in multidisciplinary meetings and patient-centered care.

Sections du résumé

BACKGROUND BACKGROUND
Periocular malignancies may be clinically different from the examples arising at other sites, with possible delayed diagnosis and greater challenges for treatment and repair. Line-field confocal optical coherence tomography (LC-OCT) is a recently developed technique characterized by an unprecedented capacity to acquire high-definition images in vertical and horizontal modes. In this study, we aimed to investigate the LC-OCT morphological features of a series of eyelid skin lesions, correlating them to histopathological findings.
METHODS METHODS
Patients with biopsy-proven equivocal skin lesion in the eyelid area, previously investigated by means of LC-OCT, were included in the study. Percentage overall agreement was estimated for LC-OCT and histopathological diagnosis for study cases.
RESULTS RESULTS
A total of 51 patients (28 women, 23 men; mean age 66.4 years old), for a total of 51 skin lesions, were assessed. The histopathological diagnosis consisted of 30 malignant and 21 benign tumors. Different entities were characterized by peculiar findings in LC-OCT, alike to histopathological features, allowing for an accurate "in vivo" classification in almost all cases, with a diagnostic concordance with histopathology of 92.1% (47/51).
CONCLUSIONS CONCLUSIONS
By integrating this new imaging technique into the assessment of suspicious tumors in this area, diagnostic accuracy may increase, improving strategies adopted in multidisciplinary meetings and patient-centered care.

Identifiants

pubmed: 38066831
pii: diagnostics13233590
doi: 10.3390/diagnostics13233590
pmc: PMC10705943
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Cutan Pathol. 2023 Feb;50(2):118-122
pubmed: 36056910
Ital J Dermatol Venerol. 2023 Jun;158(3):197-204
pubmed: 37278498
Ocul Oncol Pathol. 2021 Mar;7(2):149-158
pubmed: 33981698
J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1396-e1398
pubmed: 37458229
J Eur Acad Dermatol Venereol. 2023 Nov 1;:
pubmed: 37909307
Am Fam Physician. 1998 Jun;57(11):2695-702
pubmed: 9636333
Eye (Lond). 2015 Aug;29(8):1092-8
pubmed: 26088676
Ophthalmology. 1997 Mar;104(3):479-84
pubmed: 9082276
Cancers (Basel). 2022 Feb 23;14(5):
pubmed: 35267448
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):2388-2397
pubmed: 34415646
Cancers (Basel). 2021 Sep 30;13(19):
pubmed: 34638396
Ophthalmology. 2005 Apr;112(4):717-23
pubmed: 15808267
Adv Clin Exp Med. 2019 Mar;28(3):325-330
pubmed: 30277668
Ital J Dermatol Venerol. 2023 Jun;158(3):180-189
pubmed: 37278496
J Dermatol. 2022 Sep;49(9):851-861
pubmed: 35608155
Am J Dermatopathol. 2009 May;31(3):256-62
pubmed: 19384066
J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1234-e1236
pubmed: 37256913
J Cutan Pathol. 2021 Sep;48(9):1208-1211
pubmed: 34028070
Clin Oncol (R Coll Radiol). 2019 Jun;31(6):400
pubmed: 30879802
Cancers (Basel). 2021 Jun 08;13(12):
pubmed: 34201052
Biomed Res Int. 2015;2015:453091
pubmed: 26634208
Ital J Dermatol Venerol. 2023 Jun;158(3):171-179
pubmed: 37278495
Br J Dermatol. 2019 May;180(5):1176-1182
pubmed: 30536656
Int J Dermatol. 2021 Aug;60(8):915-924
pubmed: 33226125
Postepy Dermatol Alergol. 2021 Oct;38(5):804-807
pubmed: 34849127
Clin Exp Dermatol. 2021 Dec;46(8):1471-1481
pubmed: 34047380
JAMA Ophthalmol. 2017 Aug 1;135(8):845-851
pubmed: 28654937
Int Ophthalmol. 2023 Apr;43(4):1103-1110
pubmed: 36083562
Acta Derm Venereol. 2017 Jul 5;Suppl 218:22-30
pubmed: 28676883
Cancers (Basel). 2022 Feb 21;14(4):
pubmed: 35205830

Auteurs

Alessandro Di Stefani (A)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ocular Oncology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Simone Cappilli (S)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ocular Oncology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Giovanni Cuffaro (G)

Ocular Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ophthalmology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Bruno Fionda (B)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Monica Maria Pagliara (MM)

Ocular Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Andrea Paradisi (A)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ocular Oncology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Costantino Ricci (C)

Pathology Unit, Maggiore Hospital, AUSL Bologna, 40133 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), S. Orsola-Malpighi University Hospital, University of Bologna, 40138 Bologna, Italy.

Ernesto Rossi (E)

Medical Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Maria Grazia Sammarco (MG)

Ocular Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Giovanni Schinzari (G)

Ophthalmology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Medical Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Luca Tagliaferri (L)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Maria Antonietta Blasi (MA)

Ocular Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ophthalmology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Elisa Cinotti (E)

Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, Università degli Studi di Siena, 53100 Siena, Italy.
Groupe d'Imagerie Cutanée Non Invasive (GICNI) of the Société Française de Dermatologie (SFD), 75008 Paris, France.

Alessandro Moro (A)

Ophthalmology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Maxillo-Facial Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Gustavo Savino (G)

Ocular Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ophthalmology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Mariano Suppa (M)

Groupe d'Imagerie Cutanée Non Invasive (GICNI) of the Société Française de Dermatologie (SFD), 75008 Paris, France.
Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Department of Dermatology, Institut Jules Bordet, Université Libre de Bruxelles, 1050 Brussels, Belgium.

Ketty Peris (K)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Ocular Oncology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Classifications MeSH